Caffeine has been found to have Neuroprotective Effects in Patients with Parkinson’s Disease. Study findings published in Neurology suggest that absolute lower levels of caffeine and caffeine metabolite profiles are promising diagnostic biomarkers for early Parkinson’s Disease. This is consistent with the neuroprotective effect of caffeine previously revealed by epidemiologic and experimental studies. A study […]